Ursodiol and Zerbaxa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ursodiol (ursodiol) and Zerbaxa (ceftolozane sulfate; tazobactam sodium). Common drug interactions include pancytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Ursodiol and Zerbaxa. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Ursodiol?

Ursodiol has active ingredients of ursodiol. It is often used in primary biliary cirrhosis. eHealthMe is studying from 19,061 Ursodiol users. Check the latest studies of Ursodiol.

What is Zerbaxa?

Zerbaxa has active ingredients of ceftolozane sulfate; tazobactam sodium. eHealthMe is studying from 1,018 Zerbaxa users. Check the latest studies of Zerbaxa.

On Jul, 15, 2026

30 people who take Ursodiol and Zerbaxa together, and have interactions are studied.

What are the common drug interactions of Ursodiol and Zerbaxa, by gender? *:

female:

n/a

male:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Blood creatinine increased
Blood urea increased
Bronchial haemorrhage (bleeding in bronchia)
Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
Constipation
Cough
Cystic fibrosis (disease of the secretary glands)
Diarrhoea

What are the common drug interactions of Ursodiol and Zerbaxa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Bandaemia (excess of band cells (immature white blood cells) released by the bone marrow into the blood)
Blood creatinine increased
Blood urea increased
Bronchial haemorrhage (bleeding in bronchia)
Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
Constipation
Cough
Cystic fibrosis (disease of the secretary glands)
Diarrhoea
Dysphagia (a condition in which swallowing is difficult or painful)

40-49:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Confusional state
Cellulitis (infection under the skin)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

High Blood Pressure: 28 people, 93.33%
Pain: 28 people, 93.33%
Fungal Infection: 28 people, 93.33%
Abdominal Pain: 19 people, 63.33%
Cellulitis (infection under the skin): 19 people, 63.33%
Diarrhea: 19 people, 63.33%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 19 people, 63.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 19 people, 63.33%
Fever: 16 people, 53.33%
Cystic Fibrosis (disease of the secretary glands): 10 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ursodiol and Zerbaxa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously